RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer

被引：0
作者：
Gil-Lianes, J. [1 ]
Morgado-Carrasco, D. [1 ]
机构：
[1] Univ Barcelona, Hosp Clin Barcelona, Serv Dermatol, Barcelona, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2023年 / 114卷 / 03期
关键词：
Basal cell carcinoma; Squamous cell carcinoma; Keratoacanthoma; 5-Fluorouracil; Intralesional;
D O I：
10.1016/j.ad.2021.07.034
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：T255 / T256
页数：2
相关论文
共 5 条
  • [1] Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons
    Chitwood, Katelyn
    Etzkorn, Jeremy
    Cohen, George
    [J]. DERMATOLOGIC SURGERY, 2013, 39 (09) : 1306 - 1316
  • [2] Danesh MJ, 2021, J AM ACAD DERMATOL, V84, P1696, DOI [10.1016/j.jaad.2021.02.060, 10.1016/j.jaad.2020.12.049]
  • [3] Intralesional chemotherapy for nonmelanoma skin cancer: A practical review
    Kirby, Joslyn S.
    Miller, Christopher J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (04) : 689 - 702
  • [4] Maghfour J, 2021, J DRUGS DERMATOL, V20, P192, DOI [10.36849/JDD.5518, 10.36849/JDD.2021.5518]
  • [5] Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review
    Metterle, Lauren
    Nelson, Christopher
    Patel, Nishit
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (03) : 552 - 557
1